2018
DOI: 10.1159/000491390
|View full text |Cite
|
Sign up to set email alerts
|

Sterile Inflammatory Role of High Mobility Group Box 1 Protein: Biological Functions and Involvement in Disease

Abstract: High mobility group box 1 protein (HMGB1), a sterile inflammatory molecule and damage-associated molecular pattern (DAMP) released from various cells during stress has been implicated in inflammation. Several reports show that there is a direct relationship between inflammation and cardiovascular diseases (CVDs) such as thrombosis, hypertension, insulin resistance, preeclampsia, etc. Here, we intend to summarize the concept of the emerging link between HMGB1 and CVDs. Furthermore, we will discuss the possible … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(19 citation statements)
references
References 114 publications
(150 reference statements)
0
5
0
Order By: Relevance
“…High mobility group box-1 protein, a non-histone DNA binding protein, can activate multiple inflammatory pathways, including NFκB, extracellular regulated kinase, p38, CD24, Tolllike receptor-2, Toll-like receptor-4, Toll-like receptor-9, and the advanced glycation end-product receptor [84]. EPA has been shown to reduce high mobility group box-1 protein and TNFα by a PPARγ-dependent mechanism, and by a PPARγ-independent pathway inhibiting the glycation end-product and TLR9, which has shown to attenuate ischemic brain damage in ovariectomized rats [85].…”
Section: Inflammationmentioning
confidence: 99%
“…High mobility group box-1 protein, a non-histone DNA binding protein, can activate multiple inflammatory pathways, including NFκB, extracellular regulated kinase, p38, CD24, Tolllike receptor-2, Toll-like receptor-4, Toll-like receptor-9, and the advanced glycation end-product receptor [84]. EPA has been shown to reduce high mobility group box-1 protein and TNFα by a PPARγ-dependent mechanism, and by a PPARγ-independent pathway inhibiting the glycation end-product and TLR9, which has shown to attenuate ischemic brain damage in ovariectomized rats [85].…”
Section: Inflammationmentioning
confidence: 99%
“…High-mobility group box 1 (HMGB1) is a highly conserved non-histone DNA-binding protein ( 9 ). It has been documented that HMGB, an extracellularly released mediator, can regulate the inflammatory response ( 10 ). Typically, the production of pro-inflammatory cytokines such as TNF-α and IL-1β is induced immediately once inflammation spreads into the blood stream, which then triggers HMGB1 expression ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…Existing evidence indicates that extracellular HMGB1 may exhibit pro-inflammatory activity in the pathogenesis of various inflammatory diseases ( 12 ). HMGB1 is secreted by injured cells and innate immune cells including macrophages ( 10 , 13 ). Moreover, in response to LPS stimulation, HMGB1 can translocate from the nuclei to the cytoplasm in macrophages ( 14 ).…”
Section: Introductionmentioning
confidence: 99%
“…The interaction of HMGB1 with transmembrane receptors such as Toll-like receptors (TLR)-2, TLR-4, TLR-9, and the receptor for advanced glycation end-products (RAGE) activated pro-inflammatory cytokines including tumor necrosis factor (TNF), interleukin (IL)-1, IL-6, and IL-8. As a result, a sterile inflammatory response to tissue damage occurs 18 , 19 .…”
Section: Introductionmentioning
confidence: 99%